臭氧治疗与新型冠状病毒肺炎：靶向内皮细胞的抗氧化剂成为焦点。 - Suppr

Suppr

超能文献

Oxygen-ozone treatment and COVID-19: antioxidants targeting endothelia lead the scenery.

作者信息

Varesi Angelica, Chirumbolo Salvatore, Ricevuti Giovanni

机构信息

Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.

Almo Collegio Borromeo, Pavia, Italy.

出版信息

Intern Emerg Med. 2022 Mar;17(2):593-596. doi: 10.1007/s11739-021-02865-y. Epub 2021 Oct 22.

DOI:10.1007/s11739-021-02865-y

PMID:34677789

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8531908/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaae/8531908/c40227b6fa51/11739_2021_2865_Fig1_HTML.jpg

相似文献

Oxygen-ozone treatment and COVID-19: antioxidants targeting endothelia lead the scenery.臭氧治疗与新型冠状病毒肺炎：靶向内皮细胞的抗氧化剂成为焦点。

Intern Emerg Med. 2022 Mar;17(2):593-596. doi: 10.1007/s11739-021-02865-y. Epub 2021 Oct 22.

Potential mechanisms by which the oxygen-ozone (O2-O3) therapy could contribute to the treatment against the coronavirus COVID-19.氧-臭氧（O2-O3）疗法有助于治疗新型冠状病毒COVID-19的潜在机制。

Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4059-4061. doi: 10.26355/eurrev_202004_20976.

Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study.臭氧氧气疗法作为 SARS-CoV-2 感染急救治疗的辅助手段：一项临床研究。

J Biol Regul Homeost Agents. 2020 May-Jun;34(3):757-766. doi: 10.23812/20-250-E-56.

The need for a correct oxygen-ozone autohemotherapy (O-AHT) in patients with mild to moderate COVID-19 pneumonia.轻度至中度新冠肺炎患者对正确的氧-臭氧自血疗法（O-AHT）的需求。

Intern Emerg Med. 2021 Apr;16(3):793-794. doi: 10.1007/s11739-020-02592-w. Epub 2021 Jan 5.

Oxygen-ozone autohemotherapy against COVID-19 needs to fit highly experienced, customized, and standardized protocols to succeed.采用臭氧自血疗法治疗新冠肺炎需要符合经验丰富、量身定制且标准化的方案才能取得成功。

J Med Virol. 2021 May;93(5):2580-2582. doi: 10.1002/jmv.26806. Epub 2021 Jan 27.

Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience: reply.轻度至中度新型冠状病毒肺炎患者的血液臭氧疗法：单中心经验：回复

Intern Emerg Med. 2021 Apr;16(3):795-796. doi: 10.1007/s11739-021-02630-1. Epub 2021 Feb 3.

SARS-CoV-2 viability on different surfaces after gaseous ozone treatment: a preliminary evaluation.气态臭氧处理后不同表面上 SARS-CoV-2 的存活能力：初步评估。

J Hosp Infect. 2021 Apr;110:33-36. doi: 10.1016/j.jhin.2021.01.014. Epub 2021 Jan 28.

Oxygen-ozone (O-O) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported.用于 COVID-19 患者的氧气-臭氧（O-O）免疫疗法。初步报告的证据。

Int Immunopharmacol. 2020 Nov;88:106879. doi: 10.1016/j.intimp.2020.106879. Epub 2020 Aug 8.

Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment.气态臭氧处理对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的灭活作用

J Hosp Infect. 2020 Dec;106(4):837-838. doi: 10.1016/j.jhin.2020.10.004. Epub 2020 Oct 10.

Potential Role of Oxygen-Ozone Therapy in Treatment of COVID-19 Pneumonia.氧-臭氧疗法在新冠肺炎治疗中的潜在作用

Am J Case Rep. 2020 Aug 17;21:e925849. doi: 10.12659/AJCR.925849.

引用本文的文献

The Oxygen-Ozone Adjunct Medical Treatment According to the Protocols from the Italian Scientific Society of Oxygen-Ozone Therapy: How Ozone Applications in the Blood Can Influence Clinical Therapy Success via the Modulation of Cell Biology and Immunity.根据意大利氧-臭氧治疗科学协会的方案进行的氧-臭氧辅助医学治疗：血液中的臭氧应用如何通过调节细胞生物学和免疫来影响临床治疗效果。

Biology (Basel). 2023 Dec 11;12(12):1512. doi: 10.3390/biology12121512.

The biological activity of medical ozone in the hormetic range and the role of full expertise professionals.医用臭氧在 hormetic 范围内的生物活性及专业全才的作用

Front Public Health. 2022 Sep 16;10:979076. doi: 10.3389/fpubh.2022.979076. eCollection 2022.

The Mito-Hormetic Mechanisms of Ozone in the Clearance of SARS-CoV2 and in the COVID-19 Therapy.臭氧在清除新冠病毒及治疗新冠肺炎中的线粒体应激机制

Biomedicines. 2022 Sep 12;10(9):2258. doi: 10.3390/biomedicines10092258.

Mechanisms of Action of Ozone Therapy in Emerging Viral Diseases: Immunomodulatory Effects and Therapeutic Advantages With Reference to SARS-CoV-2.臭氧疗法在新兴病毒性疾病中的作用机制：参考SARS-CoV-2的免疫调节作用和治疗优势

Front Microbiol. 2022 Apr 21;13:871645. doi: 10.3389/fmicb.2022.871645. eCollection 2022.

本文引用的文献

SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.SARS-CoV-2 定植于冠状动脉血栓中，并损害无症状 SARS-CoV-2 阳性急性心肌梗死患者的心脏微循环床。

Crit Care. 2021 Jun 24;25(1):217. doi: 10.1186/s13054-021-03643-0.

Insights on the mechanisms of action of ozone in the medical therapy against COVID-19.关于臭氧在抗新冠病毒医学治疗中作用机制的见解。

Int Immunopharmacol. 2021 Jul;96:107777. doi: 10.1016/j.intimp.2021.107777. Epub 2021 May 11.

Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19.内皮功能障碍和免疫血栓形成是 COVID-19 的关键发病机制。

Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9. Epub 2021 Apr 6.

Oxygen-ozone (O-O) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported.用于 COVID-19 患者的氧气-臭氧（O-O）免疫疗法。初步报告的证据。

Int Immunopharmacol. 2020 Nov;88:106879. doi: 10.1016/j.intimp.2020.106879. Epub 2020 Aug 8.

Invasive mechanical ventilation in COVID-19 patient management: the experience with 469 patients in Wuhan.新型冠状病毒肺炎患者管理中的有创机械通气：武汉469例患者的经验

Crit Care. 2020 Jun 16;24(1):348. doi: 10.1186/s13054-020-03044-9.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验